Global Biologics Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 04 Sep 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

The Global Info Research report includes an overview of the development of the Biologics Contract Manufacturing industry chain, the market status of Medical Company (Monoclonal Antibodies, Recombinant Proteins), Hospital (Monoclonal Antibodies, Recombinant Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologics Contract Manufacturing.

Regionally, the report analyzes the Biologics Contract Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologics Contract Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Biologics Contract Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologics Contract Manufacturing industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Recombinant Proteins).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologics Contract Manufacturing market.

Regional Analysis: The report involves examining the Biologics Contract Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologics Contract Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Biologics Contract Manufacturing:
Company Analysis: Report covers individual Biologics Contract Manufacturing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologics Contract Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical Company, Hospital).

Technology Analysis: Report covers specific technologies relevant to Biologics Contract Manufacturing. It assesses the current state, advancements, and potential future developments in Biologics Contract Manufacturing areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologics Contract Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Biologics Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Molecular Therapy
Others

Market segment by Application
Medical Company
Hospital

Market segment by players, this report covers
Lonza Group
Samsung Biologics Co., Ltd.
Thermo Fisher Scientific, Inc.
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biologics Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologics Contract Manufacturing, with revenue, gross margin and global market share of Biologics Contract Manufacturing from 2018 to 2023.
Chapter 3, the Biologics Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologics Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics Contract Manufacturing.
Chapter 13, to describe Biologics Contract Manufacturing research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Biologics Contract Manufacturing
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Biologics Contract Manufacturing by Type
        1.3.1 Overview: Global Biologics Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Biologics Contract Manufacturing Consumption Value Market Share by Type in 2022
        1.3.3 Monoclonal Antibodies
        1.3.4 Recombinant Proteins
        1.3.5 Vaccines
        1.3.6 Molecular Therapy
        1.3.7 Others
    1.4 Global Biologics Contract Manufacturing Market by Application
        1.4.1 Overview: Global Biologics Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Medical Company
        1.4.3 Hospital
    1.5 Global Biologics Contract Manufacturing Market Size & Forecast
    1.6 Global Biologics Contract Manufacturing Market Size and Forecast by Region
        1.6.1 Global Biologics Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Biologics Contract Manufacturing Market Size by Region, (2018-2029)
        1.6.3 North America Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.4 Europe Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.6 South America Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Biologics Contract Manufacturing Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Lonza Group
        2.1.1 Lonza Group Details
        2.1.2 Lonza Group Major Business
        2.1.3 Lonza Group Biologics Contract Manufacturing Product and Solutions
        2.1.4 Lonza Group Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Lonza Group Recent Developments and Future Plans
    2.2 Samsung Biologics Co., Ltd.
        2.2.1 Samsung Biologics Co., Ltd. Details
        2.2.2 Samsung Biologics Co., Ltd. Major Business
        2.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Solutions
        2.2.4 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Samsung Biologics Co., Ltd. Recent Developments and Future Plans
    2.3 Thermo Fisher Scientific, Inc.
        2.3.1 Thermo Fisher Scientific, Inc. Details
        2.3.2 Thermo Fisher Scientific, Inc. Major Business
        2.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product and Solutions
        2.3.4 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
    2.4 Cambrex Corporation
        2.4.1 Cambrex Corporation Details
        2.4.2 Cambrex Corporation Major Business
        2.4.3 Cambrex Corporation Biologics Contract Manufacturing Product and Solutions
        2.4.4 Cambrex Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Cambrex Corporation Recent Developments and Future Plans
    2.5 Siegfried Holding AG
        2.5.1 Siegfried Holding AG Details
        2.5.2 Siegfried Holding AG Major Business
        2.5.3 Siegfried Holding AG Biologics Contract Manufacturing Product and Solutions
        2.5.4 Siegfried Holding AG Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Siegfried Holding AG Recent Developments and Future Plans
    2.6 Fujifilm Holding Corporation
        2.6.1 Fujifilm Holding Corporation Details
        2.6.2 Fujifilm Holding Corporation Major Business
        2.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Solutions
        2.6.4 Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Fujifilm Holding Corporation Recent Developments and Future Plans
    2.7 AbbVie, Inc.
        2.7.1 AbbVie, Inc. Details
        2.7.2 AbbVie, Inc. Major Business
        2.7.3 AbbVie, Inc. Biologics Contract Manufacturing Product and Solutions
        2.7.4 AbbVie, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 AbbVie, Inc. Recent Developments and Future Plans
    2.8 Boehringer Ingelheim
        2.8.1 Boehringer Ingelheim Details
        2.8.2 Boehringer Ingelheim Major Business
        2.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Product and Solutions
        2.8.4 Boehringer Ingelheim Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.9 Recipharm Pharmaceuticals
        2.9.1 Recipharm Pharmaceuticals Details
        2.9.2 Recipharm Pharmaceuticals Major Business
        2.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Solutions
        2.9.4 Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Recipharm Pharmaceuticals Recent Developments and Future Plans
    2.10 WuXi Biologics
        2.10.1 WuXi Biologics Details
        2.10.2 WuXi Biologics Major Business
        2.10.3 WuXi Biologics Biologics Contract Manufacturing Product and Solutions
        2.10.4 WuXi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 WuXi Biologics Recent Developments and Future Plans
    2.11 Catalent, Inc.
        2.11.1 Catalent, Inc. Details
        2.11.2 Catalent, Inc. Major Business
        2.11.3 Catalent, Inc. Biologics Contract Manufacturing Product and Solutions
        2.11.4 Catalent, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Catalent, Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Biologics Contract Manufacturing Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Biologics Contract Manufacturing by Company Revenue
        3.2.2 Top 3 Biologics Contract Manufacturing Players Market Share in 2022
        3.2.3 Top 6 Biologics Contract Manufacturing Players Market Share in 2022
    3.3 Biologics Contract Manufacturing Market: Overall Company Footprint Analysis
        3.3.1 Biologics Contract Manufacturing Market: Region Footprint
        3.3.2 Biologics Contract Manufacturing Market: Company Product Type Footprint
        3.3.3 Biologics Contract Manufacturing Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Biologics Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Biologics Contract Manufacturing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
    5.2 Global Biologics Contract Manufacturing Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
    6.2 North America Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
    6.3 North America Biologics Contract Manufacturing Market Size by Country
        6.3.1 North America Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
        6.3.2 United States Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        6.3.3 Canada Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        6.3.4 Mexico Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
    7.2 Europe Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
    7.3 Europe Biologics Contract Manufacturing Market Size by Country
        7.3.1 Europe Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
        7.3.2 Germany Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.3 France Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.5 Russia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.6 Italy Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Region
        8.3.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2018-2029)
        8.3.2 China Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.3 Japan Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.4 South Korea Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.5 India Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.7 Australia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
    9.2 South America Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
    9.3 South America Biologics Contract Manufacturing Market Size by Country
        9.3.1 South America Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
        9.3.2 Brazil Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        9.3.3 Argentina Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country
        10.3.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
        10.3.2 Turkey Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
        10.3.4 UAE Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Biologics Contract Manufacturing Market Drivers
    11.2 Biologics Contract Manufacturing Market Restraints
    11.3 Biologics Contract Manufacturing Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Biologics Contract Manufacturing Industry Chain
    12.2 Biologics Contract Manufacturing Upstream Analysis
    12.3 Biologics Contract Manufacturing Midstream Analysis
    12.4 Biologics Contract Manufacturing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Biologics Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Biologics Contract Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Biologics Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Biologics Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Lonza Group Company Information, Head Office, and Major Competitors
    Table 6. Lonza Group Major Business
    Table 7. Lonza Group Biologics Contract Manufacturing Product and Solutions
    Table 8. Lonza Group Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Lonza Group Recent Developments and Future Plans
    Table 10. Samsung Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
    Table 11. Samsung Biologics Co., Ltd. Major Business
    Table 12. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Solutions
    Table 13. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Samsung Biologics Co., Ltd. Recent Developments and Future Plans
    Table 15. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
    Table 16. Thermo Fisher Scientific, Inc. Major Business
    Table 17. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product and Solutions
    Table 18. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
    Table 20. Cambrex Corporation Company Information, Head Office, and Major Competitors
    Table 21. Cambrex Corporation Major Business
    Table 22. Cambrex Corporation Biologics Contract Manufacturing Product and Solutions
    Table 23. Cambrex Corporation Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Cambrex Corporation Recent Developments and Future Plans
    Table 25. Siegfried Holding AG Company Information, Head Office, and Major Competitors
    Table 26. Siegfried Holding AG Major Business
    Table 27. Siegfried Holding AG Biologics Contract Manufacturing Product and Solutions
    Table 28. Siegfried Holding AG Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Siegfried Holding AG Recent Developments and Future Plans
    Table 30. Fujifilm Holding Corporation Company Information, Head Office, and Major Competitors
    Table 31. Fujifilm Holding Corporation Major Business
    Table 32. Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Solutions
    Table 33. Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Fujifilm Holding Corporation Recent Developments and Future Plans
    Table 35. AbbVie, Inc. Company Information, Head Office, and Major Competitors
    Table 36. AbbVie, Inc. Major Business
    Table 37. AbbVie, Inc. Biologics Contract Manufacturing Product and Solutions
    Table 38. AbbVie, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. AbbVie, Inc. Recent Developments and Future Plans
    Table 40. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 41. Boehringer Ingelheim Major Business
    Table 42. Boehringer Ingelheim Biologics Contract Manufacturing Product and Solutions
    Table 43. Boehringer Ingelheim Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Boehringer Ingelheim Recent Developments and Future Plans
    Table 45. Recipharm Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 46. Recipharm Pharmaceuticals Major Business
    Table 47. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Solutions
    Table 48. Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Recipharm Pharmaceuticals Recent Developments and Future Plans
    Table 50. WuXi Biologics Company Information, Head Office, and Major Competitors
    Table 51. WuXi Biologics Major Business
    Table 52. WuXi Biologics Biologics Contract Manufacturing Product and Solutions
    Table 53. WuXi Biologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. WuXi Biologics Recent Developments and Future Plans
    Table 55. Catalent, Inc. Company Information, Head Office, and Major Competitors
    Table 56. Catalent, Inc. Major Business
    Table 57. Catalent, Inc. Biologics Contract Manufacturing Product and Solutions
    Table 58. Catalent, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Catalent, Inc. Recent Developments and Future Plans
    Table 60. Global Biologics Contract Manufacturing Revenue (USD Million) by Players (2018-2023)
    Table 61. Global Biologics Contract Manufacturing Revenue Share by Players (2018-2023)
    Table 62. Breakdown of Biologics Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Biologics Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key Biologics Contract Manufacturing Players
    Table 65. Biologics Contract Manufacturing Market: Company Product Type Footprint
    Table 66. Biologics Contract Manufacturing Market: Company Product Application Footprint
    Table 67. Biologics Contract Manufacturing New Market Entrants and Barriers to Market Entry
    Table 68. Biologics Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Biologics Contract Manufacturing Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global Biologics Contract Manufacturing Consumption Value Share by Type (2018-2023)
    Table 71. Global Biologics Contract Manufacturing Consumption Value Forecast by Type (2024-2029)
    Table 72. Global Biologics Contract Manufacturing Consumption Value by Application (2018-2023)
    Table 73. Global Biologics Contract Manufacturing Consumption Value Forecast by Application (2024-2029)
    Table 74. North America Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. Biologics Contract Manufacturing Raw Material
    Table 105. Key Suppliers of Biologics Contract Manufacturing Raw Materials
List of Figures
    Figure 1. Biologics Contract Manufacturing Picture
    Figure 2. Global Biologics Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Biologics Contract Manufacturing Consumption Value Market Share by Type in 2022
    Figure 4. Monoclonal Antibodies
    Figure 5. Recombinant Proteins
    Figure 6. Vaccines
    Figure 7. Molecular Therapy
    Figure 8. Others
    Figure 9. Global Biologics Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Biologics Contract Manufacturing Consumption Value Market Share by Application in 2022
    Figure 11. Medical Company Picture
    Figure 12. Hospital Picture
    Figure 13. Global Biologics Contract Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Biologics Contract Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Biologics Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Biologics Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Biologics Contract Manufacturing Consumption Value Market Share by Region in 2022
    Figure 18. North America Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Biologics Contract Manufacturing Revenue Share by Players in 2022
    Figure 24. Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Biologics Contract Manufacturing Market Share in 2022
    Figure 26. Global Top 6 Players Biologics Contract Manufacturing Market Share in 2022
    Figure 27. Global Biologics Contract Manufacturing Consumption Value Share by Type (2018-2023)
    Figure 28. Global Biologics Contract Manufacturing Market Share Forecast by Type (2024-2029)
    Figure 29. Global Biologics Contract Manufacturing Consumption Value Share by Application (2018-2023)
    Figure 30. Global Biologics Contract Manufacturing Market Share Forecast by Application (2024-2029)
    Figure 31. North America Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 65. Biologics Contract Manufacturing Market Drivers
    Figure 66. Biologics Contract Manufacturing Market Restraints
    Figure 67. Biologics Contract Manufacturing Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Biologics Contract Manufacturing in 2022
    Figure 70. Manufacturing Process Analysis of Biologics Contract Manufacturing
    Figure 71. Biologics Contract Manufacturing Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonza Group
Samsung Biologics Co., Ltd.
Thermo Fisher Scientific, Inc.
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.

Related Reports

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

date 04 Sep 2023

date Service & Software

The global Biologics Contract Manufacturing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Biologics Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Biologics Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Service & Software

The global Biologics Contract Manufacturing market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Biologics Contract Manufacturing

Biologics Contract Manufacturing Service

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>